medRxiv PreprintsInternational20 November 2026
DYCAST early warning system for dengue virus risk areas, Ribeirao Preto, Brazil
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Dengue is currently the fastest-spreading vector-borne disease, with an estimated 100-400 million infections per year and nearly 6 billion people at risk--more than half the world's population. However, there is no specific antiviral treatment, thus the primary method for preventing infection is through targeted control of the principal mosquito vector, Aedes aegypti. The objective of this retrospective study is to evaluate the efficacy of forecasting dengue risk using human cases and an adaptation of DYCAST: a biologically based, spatiotemporal clustering model that proved operationally succe
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.